Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 57% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $80.0 to $160.0 for Moderna over the last 3 months. The price of MRNA is down -6.42% at $91.99, and RSI indicators suggest that the stock may be oversold. The next earnings are expected to be released in 17 days.
October 16, 2023 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A significant investor has taken a bearish stance on Moderna. The stock price is down -6.42% at $91.99, and RSI indicators suggest that the stock may be oversold. The next earnings are expected to be released in 17 days.
The bearish stance taken by a significant investor, along with the current price drop and oversold indicators, suggest a negative short-term impact on Moderna's stock. The upcoming earnings release could further influence the stock's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100